0 Comments
0 Shares
326 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Global Epilepsy Therapeutics Market to Reach US$ 18.24 Billion by 2033 from US$ 14.63 Billion | CAGR 3.2% (2025–2033) | AI-Driven Healthcare, Precision Medicine Boom & Future of Lifesciences Power Next-Generation NeurologyGlobal Epilepsy Therapeutics Market to Reach US$ 18.24 Billion by 2033 from US$ 14.63 Billion | CAGR 3.2% (2025–2033) | AI-Driven Healthcare, Precision Medicine Boom & Future of Lifesciences Power Next-Generation Neurology The Global Epilepsy Therapeutics Market is entering a transformative growth phase as advances in neuroscience, precision medicine,...0 Comments 0 Shares 661 Views 0 Reviews
-
Neurological Biomarkers Market Outlook for Biomarker-Based TherapeuticsThe neurological biomarkers market is entering a transformative phase as healthcare and pharmaceutical research increasingly seek faster, more precise, and less invasive ways to understand neurological disorders. Biomarkers are becoming important not only for diagnosis but also for determining disease progression, evaluating treatment response, supporting patient stratification, and improving...0 Comments 0 Shares 23 Views 0 Reviews
-
Dysautonomia Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Dysautonomia Market Data Bridge Market Research analyses a growth rate in the dysautonomia market in the forecast period 2023-2030. The expected CAGR of dysautonomia market is tend to be around 12% in the mentioned forecast period. The market was valued at USD 2708.03 million in 2022, and it would grow upto...0 Comments 0 Shares 5K Views 0 Reviews